Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)

CUSIP: 45254E107

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Class A common stock, par value $0.001 per share
Shares outstanding
66,027,379
Total 13F shares
31,752,244
Share change
+3,008,255
Total reported value
$208,911,171
Put/Call ratio
34%
Price per share
$6.58
Number of holders
87
Value change
+$18,277,430
Number of buys
55
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 45254E107?
CUSIP 45254E107 identifies IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q4 2025

As of 31 Dec 2025, Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,752,244 shares. The largest 10 holders included FMR LLC, Sanofi, Empery Asset Management, LP, VANGUARD GROUP INC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., MARSHALL WACE, LLP, Blue Owl Capital Holdings LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 87 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.